VILIP-3 inhibitors represent a class of chemical compounds designed to modulate the activity of VILIP-3, a member of the neuronal calcium sensor protein family. These inhibitors are primarily employed in research settings to investigate the biological functions and signaling pathways associated with VILIP-3, rather than for applications. VILIP-3, also known as Visinin-like Protein 3, is a calcium-binding protein predominantly expressed in the nervous system, where it plays a significant role in calcium-dependent signaling processes. It is closely related to other calcium sensor proteins like calmodulin and recoverin.
The mechanism of action of VILIP-3 inhibitors typically involves interference with intracellular calcium signaling pathways. Calcium ions are critical secondary messengers in various cellular processes, including neurotransmission and synaptic plasticity. VILIP-3 interacts with calcium, leading to changes in its conformation and subsequent engagement in downstream signaling events. VILIP-3 inhibitors, such as small molecules and compounds like calcium channel blockers, modulate this interaction by either reducing the availability of free calcium ions in the intracellular environment or by directly interfering with VILIP-3's ability to bind to calcium. By doing so, these inhibitors allow researchers to elucidate the specific functions of VILIP-3 and its impact on neuronal physiology and related processes. In summary, VILIP-3 inhibitors are valuable tools for studying the intricate role of VILIP-3 in calcium-dependent signaling pathways within neurons and other relevant cellular systems, contributing to a deeper understanding of the molecular mechanisms underlying neuronal function and synaptic plasticity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits VILIP-3 by reducing intracellular calcium levels through blockade of inositol phosphate signaling pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Binds to calcium ions, inhibiting their interaction with VILIP-3, thereby disrupting its calcium-dependent functions. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
Blocks calcium channels, reducing the intracellular calcium concentration and inhibiting VILIP-3 activation. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Inhibits VILIP-3 by suppressing Ca2+/calmodulin-dependent protein kinase II (CaMKII) activity, which is essential for VILIP-3 function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Acts as a calcium channel blocker, decreasing intracellular calcium levels and consequently inhibiting VILIP-3. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Blocks calcium channels, reducing intracellular calcium levels and inhibiting VILIP-3 activation. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $188.00 $250.00 | 13 | |
Inhibits calcium release from intracellular stores, disrupting the calcium-dependent functions of VILIP-3. | ||||||
Gadolinium(III) chloride | 10138-52-0 | sc-224004 sc-224004A | 5 g 25 g | $153.00 $357.00 | 4 | |
Blocks calcium-permeable ion channels, reducing intracellular calcium levels and inhibiting VILIP-3 activation. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Acts as a calcium channel blocker, reducing intracellular calcium concentrations and inhibiting VILIP-3. | ||||||
Laurocapram | 59227-89-3 | sc-353659 | 25 ml | $360.00 | ||
Interferes with calcium homeostasis, leading to decreased intracellular calcium and inhibition of VILIP-3 activity. | ||||||